American Renal Associates Holdings, Inc.
Healthcare · Services-Misc Health & Allied Services, NEC · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY19 | FY18 | FY17 | FY16 | FY15 | |
|---|---|---|---|---|---|
| Revenue | $191.8M | $186.3M | — | — | — |
| Operating income | $2.6M | $12.6M | $90.2M | $48.8M | $150.8M |
| Net income | −$10.5M | −$3.8M | −$4.6M | $6.5M | $18.8M |
| Total assets | $1.09B | $985.8M | $1.02B | $993.1M | $938.3M |
| Total liabilities | $875.8M | $746.8M | $704.7M | $797.0M | $779.4M |
| Equity | −$79.5M | −$59.0M | −$37.9M | −$31.1M | −$123.2M |
| EPS (diluted) | $-0.35 | $-0.10 | $-0.52 | $0.29 | $0.83 |
| Shares out. | 32.6M | 32.0M | 30.9M | 29.8M | 22.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2019- Operating margin
- 1.4%
- Net margin
- −5.5%
- Return on equity
- 13.2%
- Return on assets
- −1.0%
- Return on capital (ROCE)
- 0.3%
- Liabilities / assets
- 80.6%
- Debt / equity
- —
- Book value / share
- $-2.44
- Revenue growth (YoY)
- 2.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2019- Altman Z″ (distress)
- -0.44distress
- Accruals / assets
- −4.5%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 2 warning● 4 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 9, 2019
- NT 10-Qmissed a reporting deadline ↗May 10, 2019
- NT 10-Kmissed a reporting deadline ↗Mar 8, 2019
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Regulation FD disclosureJan 26, 2021
- Shareholder voteJan 14, 2021
- Results of operationsNov 6, 2020
- Entered a material agreement · Regulation FD disclosureOct 2, 2020
- Other material eventSep 18, 2020
- Results of operationsAug 10, 2020
- Changed auditorJul 9, 2020
- Results of operationsMay 11, 2020
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BFeb 5, 2021
- EFFECTJan 29, 2021
- SC 13G/AAMERICAN RENAL ASSOCIATES HOLDINGS, INC.Jan 27, 2021
- 4Jan 27, 2021
- 4FORM 4Jan 26, 2021
- 4FORM 4Jan 26, 2021
- 4FORM 4Jan 26, 2021
- 4FORM 4Jan 26, 2021
- 4FORM 4Jan 26, 2021
- 4FORM 4Jan 26, 2021
- 4FORM 4Jan 26, 2021
- 4FORM 4Jan 26, 2021
- 4FORM 4Jan 26, 2021
- POS AMJan 26, 2021
- S-8 POSJan 26, 2021